MedTrace Logo

Study of Microwave Spherical Ablation and Traditional Microwave Ablation in Single Hepatocellular Carcinoma ≤5cm

NCT05361538 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-12-14

No results posted yet for this study

Summary

Comparison of the progression-free survival, overall survival, local progression rates, complete ablation rates and the complications rate of MSA and traditional MWA in the treatment of single hepatocellular carcinoma with a diameter of ≤5cm.

Conditions

  • Hepatocellular Cancer
  • Microwave Ablation
  • Microwave Spherical Ablation
  • Prognosis

Interventions

DEVICE

True circular microwave needle

Use true circular microwave needle for thermal ablation

Sponsors & Collaborators

  • Tianjin Third Central Hospital

    lead OTHER

Principal Investigators

  • Xiang Jing · Tianjin Third Central Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-22
Primary Completion
2023-06-01
Completion
2025-06-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05361538 on ClinicalTrials.gov